A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors

被引：0
|
作者：
Hope E. Uronis
Jingquan Jia
Johanna C. Bendell
Leigh Howard
Neal A. Ready
Paula H. Lee
Mark D. Starr
Andrew Dellinger
Herbert Pang
Andrew B. Nixon
Herbert I. Hurwitz
机构：
[1] Duke University Medical Center,Duke Cancer Institute
[2] Sarah Cannon Research Institute,Department of Biostatistics and Bioinformatics
[3] Duke University Medical Center,Brody School of Medicine
[4] East Carolina University,Department of Mathematics and Statistics
[5] Elon University,School of Public Health
[6] Li Ka Shing Faculty of Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 75卷
关键词：
Intetumumab; Bevacizumab; Angiogenesis; Phase I;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 352
页数：9
相关论文
共 50 条
  • [21] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [22] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
  • [23] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    Schelman, William R.
    Morgan-Meadows, Sherry
    Marnocha, Rebecca
    Lee, Fred
    Eickhoff, Jens
    Huang, Wei
    Pomplun, Marcia
    Jiang, Zhisheng
    Alberti, Dona
    Kolesar, Jill M.
    Ivy, Percy
    Wilding, George
    Traynor, Anne M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (06) : 1147 - 1156
  • [24] A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors
    Rini, Brian I.
    Garcia, Jorge A.
    Cooney, Matthew M.
    Elson, Paul
    Tyler, Allison
    Beatty, Kristi
    Bokar, Joseph
    Mekhail, Tarek
    Bukowski, R. M.
    Budd, G. Thomas
    Triozzi, Pierre
    Borden, Ernest
    Ivy, Percy
    Chen, Helen X.
    Dolwati, Afshin
    Dreicer, Robert
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6277 - 6283
  • [25] A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
    Gordana Vlahovic
    Kellen L. Meadows
    Hope E. Uronis
    Michael A. Morse
    Gerard C. Blobe
    Richard F. Riedel
    S. Yousuf Zafar
    Angeles Alvarez-Secord
    Jon Gockerman
    Alexander N. Starodub
    Neal E. Ready
    Elizabeth L. Anderson
    Johanna C. Bendell
    Herbert I. Hurwitz
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 95 - 102
  • [26] A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
    William R. Schelman
    Sherry Morgan-Meadows
    Rebecca Marnocha
    Fred Lee
    Jens Eickhoff
    Wei Huang
    Marcia Pomplun
    Zhisheng Jiang
    Dona Alberti
    Jill M. Kolesar
    Percy Ivy
    George Wilding
    Anne M. Traynor
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 1147 - 1156
  • [27] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [28] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Kyriakopoulos, Christos E.
    Braden, Amy M.
    Kolesar, Jill M.
    Eickhoff, Jens C.
    Bailey, Howard H.
    Heideman, Jennifer
    Liu, Glenn
    Wisinski, Kari B.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (03) : 290 - 297
  • [29] A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
    Vlahovic, Gordana
    Meadows, Kellen L.
    Uronis, Hope E.
    Morse, Michael A.
    Blobe, Gerard C.
    Riedel, Richard F.
    Zafar, S. Yousuf
    Alvarez-Secord, Angeles
    Gockerman, Jon
    Starodub, Alexander N.
    Ready, Neal E.
    Anderson, Elizabeth L.
    Bendell, Johanna C.
    Hurwitz, Herbert I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 95 - 102
  • [30] A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors
    Nelson, Blessie Elizabeth
    Tsimberidou, Apostolia M.
    Fu, Xueyao
    Fu, Siqing
    Subbiah, Vivek
    Sood, Anil K.
    Rodon, Jordi
    Karp, Daniel D.
    Blumenschein, George
    Kopetz, Scott
    Pant, Shubham
    Piha-Paul, Sarina A.
    ONCOLOGIST, 2023, : e1100 - e1292
12345